| NCT03121222 | Aristotle University Of Thessaloniki|National and Kapodistrian University of Athens|European University Cyprus | Glutathione Metabolism Anemias | 2015-11-01 | PHASE2 |
| NCT01404754 | Resilient Pharmaceuticals | Psychological Effects of Study Drug | 2011-04-09 | PHASE1 |
| NCT03476447 | Evolve BioSystems, Inc.|University of California, Davis | Gut Microbiome | 2018-04-06 | NA |
| NCT03878511 | Peter Humaidan | Bacterial Vaginoses | 2012-11-01 | NA |
| NCT01151306 | University of Nottingham | Chronic Obstructive Pulmonary Disease | 2010-06 | PHASE4 |
| NCT01659307 | Belfast Health and Social Care Trust|The Intensive Care Society United Kingdom|Northern Ireland Clinical Trials Unit|Queen´s University, Belfast | Acute Lung Injury | 2012-09 | PHASE2 |
| NCT00351117 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph´s | Raynaud´s Disease | 2007-03 | PHASE3 |
| NCT06177938 | ETH Zurich|Agroscope Liebefeld-Posieux Research Station ALP|Swiss Allergy Centre|University of Zurich | Lactose Intolerance | 2024-06-24 | NA |
| NCT01041755 | Centro Regional para el Estudio de las Enfermedades Digestivas|MERZ PHARMA | Hepatic Encephalopathy | 2009-11 | PHASE4 |
| NCT00876161 | Ansun Biopharma, Inc.|National Institute of Allergy and Infectious Diseases (NIAID) | Healthy | 2009-05-18 | PHASE1 |
| NCT03063931 | University Hospital, Clermont-Ferrand | Neuropathic Pain Induced by Mastectomy | 2017-03 | PHASE2 |
| NCT00983177 | Bnai Zion Medical Center | Calcific Tendonitis | 2010-03 | NA |
| NCT01550107 | University of Dundee | Sarcopenia | 2015-02-01 | PHASE4 |
| NCT03008252 | University of Palermo | Non-celiac Wheat Sensitivity | 2017-01-01 | |
| NCT02065076 | Maisonneuve-Rosemont Hospital|Université de Montréal | Hyperkalemia|Chronic Kidney Failure | 2014-02 | PHASE4 |
| NCT02787707 | Mashhad University of Medical Sciences | Nausea|Vomiting | 2015-10 | PHASE2 |
| NCT01536314 | University Hospital, Clermont-Ferrand | Neuropathic Pain | 2012-02 | PHASE3 |
| NCT05001997 | University of Central Lancashire | Irritable Bowel Syndrome | 2021-09 | NA |
| NCT03423667 | Salvatore Campanella | Cocaine Addiction | 2019-03-01 | PHASE2 |
| NCT01014338 | Imperial College London|Medical Research Council | Chronic Obstructive Pulmonary Disease | 2009-10 | PHASE4 |
| NCT01644877 | Ansun Biopharma, Inc. | Parainfluenza | 2014-03 | PHASE2 |
| NCT02042521 | Centre for Addiction and Mental Health | Nicotine Dependence, Cigarettes, With Withdrawal | 2014-01 | PHASE2 |
| NCT01840384 | PT. Sari Husada | Anemia, Iron-deficiency | 2013-07 | NA |
| NCT03629288 | Universidad Nacional Andres Bello | Periodontitis | 2016-03-01 | NA |
| NCT00624754 | Assistance Publique - H?pitaux de Paris|AstraZeneca | Obstructive Airway Disease | 2008-03 | PHASE2 |
| NCT00256022 | Melbourne Health|Intensive Care Unit Research Department, Royal Melbourne Hospital | Preoperative Cardiac Surgery Patients | 2007-07 | NA |
| NCT00979056 | Dr. Philipp Zanger, MD MSc DTM | Diarrhoea | 2009-10 | PHASE3 |
| NCT02214095 | Ain Shams University | Chronic Periodontitis | 2012-01 | EARLY_PHASE1 |
| NCT02999022 | Sunnybrook Health Sciences Centre|Canadian Institutes of Health Research (CIHR) | Fractures | 2017-07-21 | PHASE2 |
| NCT04389931 | Universidad Nacional Andres Bello | Periodontitis | 2016-03 | NA |
| NCT04796480 | Services Hospital, Lahore | Acute Diarrhea | 2018-06-10 | NA |
| NCT02533648 | Hospices Civils de Lyon | Type 2 Diabetes Mellitus | 2011-09-16 | PHASE3 |
| NCT01320345 | University of Sydney|National Health and Medical Research Council, Australia|Juvenile Diabetes Research Foundation Australia|Mylan Pharmaceuticals Inc | Type 1 Diabetes Mellitus|Diabetic Retinopathy|Diabetic Nephropathies | 2016-11-03 | PHASE3 |
| NCT00682214 | Indian Council of Medical Research | Vitamin D Deficiency | 2008-05 | PHASE1 |
| NCT04481971 | King Saud University | Endodontics|Pain | 2020-08-09 | PHASE2 |
| NCT00902616 | Tameside Hospital NHS Foundation Trust | Type 2 Diabetes | 2003-06 | PHASE4 |
| NCT02566798 | Nantes University Hospital | Osteoarthritis | 2015-12 | NA |
| NCT05245175 | Fraunhofer-Institute of Toxicology and Experimental Medicine | Allergic Rhinitis | 2022-02-22 | NA |
| NCT04662619 | Johnson & Johnson Consumer Inc. (J&JCI)|Infinant Health, Inc. (formerly known as Evolve BioSystems, Inc.) | Healthy | 2020-12-18 | NA |
| NCT03497598 | Kantonsspital Aarau | Urinary Tract Infections | 2018-05-09 | PHASE4 |
| NCT06746285 | Persephone Biosciences | Gastrointestinal Tolerance of Probiotics in Infants | 2025-01-01 | NA |
| NCT06541938 | McMaster University | Inflammatory Bowel Diseases | 2024-08-28 | NA |
| NCT01185418 | Chonbuk National University Hospital | Normal Volunteers | 2009-03 | |
| NCT02326350 | Belfast Health and Social Care Trust|Queen´s University, Belfast|Northern Ireland Clinical Trials Unit | Acute Respiratory Distress Syndrome | 2015-02-06 | PHASE2 |
| NCT06789068 | Ain Shams University | Lactose Intolerance | 2022-11-10 | NA |
| NCT01512316 | Universitaire Ziekenhuizen KU Leuven | Healthy Individuals | | NA |
| NCT01277237 | University of Edinburgh|NHS Lothian | Non Alcoholic Fatty Liver Disease | 2010-09 | PHASE3 |
| NCT03549936 | MetroHealth Medical Center | Neonatal Abstinence Syndrome | 2014-07-09 | NA |
| NCT00755950 | University of Maryland, Baltimore|MADAUS GmbH|The Egyptian Company for Blood Transfusion Services|Tanta Fever Hospital|Banha Fever Hospital|Alexandria University | Acute Hepatitis A|Acute Hepatitis B|Acute Hepatitis C|Acute Hepatitis E|Acute EBV Hepatitis|Acute CMV Hepatitis | 2008-10 | PHASE2|PHASE3 |
| NCT00256087 | Melbourne Health | Critical Illness | 2005-01 | NA |
| NCT03582176 | University of Calgary|United States Department of Defense | Elbow Fracture|Elbow Injury|Elbow Dislocation | 2019-04-26 | PHASE3 |
| NCT00507000 | Indian Council of Medical Research|Ministry of Science and Technology, India | Tuberculosis | 2008-05 | PHASE3 |
| NCT02849275 | University of Illinois at Urbana-Champaign | Physiological Stress|Cognition - Other | 2016-08 | NA |
| NCT00888680 | Boston Scientific Corporation | Migraine | | PHASE2 |
| NCT02172508 | Boehringer Ingelheim | Pulmonary Disease, Chronic Obstructive | 2004-01 | PHASE4 |
| NCT01848119 | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Pain | 2013-05 | NA |
| NCT00504946 | Medical University of Lodz | Asthma | 2005-09 | PHASE3 |
| NCT01190683 | Indian Council of Medical Research | Vitamin D Deficiency | 2010-08 | PHASE3 |
| NCT03670212 | Wayne State University|National Institute on Drug Abuse (NIDA) | Cigarette Smoking | 2016-01-07 | PHASE1 |
| NCT01136317 | Nantes University Hospital | Gastroesophageal Reflux | 2010-04 | PHASE2 |
| NCT04551937 | University of Illinois at Urbana-Champaign | Physiological Stress|Cognitive Change|Gastrointestinal Health | 2018-02-14 | NA |
| NCT03713346 | Purdue University | Dairy Intolerance | 2018-01-17 | NA |
| NCT00403923 | University Hospitals, Leicester | Lactose Intolerance|Ulcerative Colitis | 2007-04 | |
| NCT04237090 | Ciusss de L´Est de l´?le de Montréal | Breast Cancer|Lung Cancer|Ovarian Cancer|Oesophageal Cancer|Head Cancer Neck|Cervical Cancer|Endometrial Cancer | 2020-02-14 | PHASE3 |
| NCT02145780 | Hospices Civils de Lyon | Overfeeding | 2014-02 | NA |
| NCT00573664 | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Pain | 2007-11 | NA |
| NCT01098318 | University of Pennsylvania|National Center for Complementary and Integrative Health (NCCIH) | Depression | 2010-06 | PHASE3 |
| NCT03666572 | International Centre for Diarrhoeal Disease Research, Bangladesh | Severe Acute Malnutrition | 2018-09-21 | PHASE2 |
| NCT00090064 | Resilient Pharmaceuticals | Posttraumatic Stress Disorder | 2004-03-12 | PHASE2 |
| NCT02557269 | Association Asthma, Bulgaria|Nasaleze | Seasonal Allergic Rhinitis | 2015-05 | PHASE4 |
| NCT06724705 | University of Maryland, College Park | Lactose Intolerance, Adult Type | 2024-12-05 | NA |
| NCT02448940 | Urmia University of Medical Sciences | Overweight and Obesity | 2014-02 | NA |
| NCT02936297 | Thomas Jefferson University | Non Celiac Gluten Sensitivity | 2016-06 | NA |
| NCT01497314 | Perrigo Nutritionals | Growth|Healthy Term Infants | 2011-12 | NA |
| NCT04791943 | Montefiore Medical Center|Quest Diagnostics-Nichols Insitute|Eurofins Viracor | Pain, Postoperative|Narcotic Use | 2021-11-16 | PHASE2 |
| NCT01127126 | University of Zurich | Overactive Bladder | 2010-12 | PHASE2 |
| NCT06295575 | Nanjing Children´s Hospital | Congenital Heart Disease|Intestinal Disease|Dysbiosis | 2021-06-01 | NA |
| NCT01812967 | University of Toronto | Glycemic Control|Gastrointestinal Hormone Response|Healthy Young Men | | NA |
| NCT00599859 | Sir Mortimer B. Davis - Jewish General Hospital|Danone Institute International | Lactose Intolerance | 2006-09 | NA |
| NCT02441296 | Ume? University|University of California, Davis|Mead Johnson Nutrition | Infant|Metabolism | 2013-10 | NA |
| NCT02596360 | University Hospital, Clermont-Ferrand | Experimental Pain|Hyperalgesia | 2015-11 | PHASE1 |
| NCT02286960 | NYU Langone Health | Dysphonia | 2013-07 | PHASE4 |
| NCT01400906 | GlaxoSmithKline | Asthma | 2011-07-20 | PHASE2 |
| NCT02246010 | American University of Beirut Medical Center | Acute Gastroenteritis | 2015-07-01 | NA |
| NCT02584439 | University Hospital, Rouen|Institut National de la Santé Et de la Recherche Médicale, France | Healthy|Vascular Stiffness|Aging | 2015-12-03 | PHASE3 |
| NCT04265053 | University of Wisconsin, Madison|National Heart, Lung, and Blood Institute (NHLBI) | Cerebral Arterial Diseases | 2021-04-12 | EARLY_PHASE1 |
| NCT01099332 | Adeona Pharmaceuticals | Alzheimer´s Disease|Mild Cognitive Impairment | 2009-11 | PHASE1|PHASE2 |
| NCT03161652 | Carmen Clapp|Instituto Mexicano de Oftalmologia (IMO)|Universidad Autónoma de Querétaro|General Hospital Nuremberg & Paracelsus Medical University Nuremberg|Instituto de la Retina del Bajio SC (INDEREB)|Instituto de Neurobiología, Universidad Nacional Autonoma de Mexico (UNAM) | Diabetic Macular Edema|Diabetic Retinopathy | 2017-05-24 | PHASE2 |
| NCT01040429 | Oslo University Hospital | Chronic Fatigue Syndrome|Myalgic Encephalomyelitis | 2010-02 | PHASE2 |
| NCT04205045 | Paola Vitaglione | Healthy Subjects | 2018-10-01 | |
| NCT01288781 | Bangor University|Universita di Verona|North Wales Research Committee, UK | High Altitude Headache | 2011-07 | NA |
| NCT01028014 | University of Alabama at Birmingham|Astellas Pharma Inc | Urethral Sphincter Activity | 2010-04 | NA |
| NCT05129384 | Evolve BioSystems, Inc. | Infantile Colic | 2022-02-23 | NA |
| NCT04894617 | Copenhagen University Hospital, Hvidovre|University of Copenhagen | Covid19 | 2021-06-01 | PHASE3 |
| NCT03994055 | National Institute of Cancerología | Cervical Cancer|Uterine Cervical Neoplasm|Pelvic Inflammatory Disease|Radiation Toxicity|Diet Modification | 2018-11-16 | NA |
| NCT02175342 | Boehringer Ingelheim | Pulmonary Disease, Chronic Obstructive | 1998-03-01 | PHASE2 |
| NCT03966859 | University of Oxford|Wellcome Trust | Healthy | 2019-06-19 | NA |
| NCT03464708 | Guy´s and St Thomas´ NHS Foundation Trust | Critical Illness | 2018-06-18 | PHASE2 |
| NCT01840891 | University of Zurich | Chronic Diarrhea | 2013-04 | NA |
| NCT05734612 | Indonesia University | Reperfusion Injury, Myocardial | 2022-12-04 | PHASE3 |
| NCT01675986 | Poitiers University Hospital | Feeling Anxious | | PHASE2 |
| NCT06874608 | Meyer Children´s Hospital IRCCS | Juvenile Idiopathic Arthritis (JIA) | 2024-12-12 | NA |
| NCT04543474 | Cantonal Hospital of St. Gallen | IBS - Irritable Bowel Syndrome | 2015-03-11 | NA |
| NCT01602185 | University Hospital, Clermont-Ferrand|Dr Malou Navez, Pain Clinic, Saint-Etienne Hopital|Dr Marc Sorel, Pain Clinic, Nemours Hospital|Dr Anne-Margot Duclot, Pain Clinic, Paris Rotschild Hospital|Dr Monique Belon, Pain Clinic, Aurillac Hospital|Dr Marie-Christine Crosmary+Dr Renato Colamarino, Pain Clinic, Vichy Hospital|Dr Mohamed El Ayadi, Pain Clinic, Issoire Hospital|Dr Géraldine Brumauld de Montgazon, Pain Clinic, La Rochelle Hospital | Neuropathic Pain | 2012-05 | PHASE2 |
| NCT04924530 | University of Bath|University of Oxford|British Heart Foundation | Cardiovascular Risk Factor|Lipaemia|Metabolic Disease | 2021-06-07 | NA |
| NCT00149630 | Baylor College of Medicine|National Institute on Drug Abuse (NIDA)|Yale University | Cocaine Dependence|Opioid Dependence | 2005-01 | PHASE2 |
| NCT01504867 | Mayo Clinic|Beth Israel Deaconess Medical Center|Montefiore Medical Center|Vanderbilt University Medical Center|National Heart, Lung, and Blood Institute (NHLBI)|National Center for Research Resources (NCRR) | Acute Respiratory Distress Syndrome | 2012-01 | PHASE2 |
| NCT00361543 | The Alfred|Stanley Medical Research Institute|National Health and Medical Research Council, Australia | Schizophrenia|Schizoaffective Disorder|Schizophreniform Disorder | 2006-08 | PHASE4 |
| NCT02097706 | The Alfred | Borderline Personality Disorder | 2015-01 | PHASE2 |
| NCT00872092 | University Hospital, Bonn | Malabsorption Syndromes | 1997-10 | |
| NCT00841230 | University Hospital, Antwerp | Tinnitus | 2009-02 | PHASE4 |
| NCT01575678 | University of Aarhus | Nocturnal Enuresis | 2012-01 | PHASE2 |
| NCT01094925 | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Pain | 2010-04 | NA |
| NCT01387425 | Universita degli Studi di Catania | Smoking Cessation|Diabetes | 2011-06 | NA |
| NCT02636413 | VenterPharma | Lactose Intolerance | 2015-10 | PHASE4 |